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Abstract
Background: Joint pain, including back pain, and arthritis are common conditions in the United States, affecting
more than 100 million individuals and costing upwards of $200 billion each year. Although activity limitations
associated with these disorders impose a substantial economic burden, this relationship has not been explored in
a large U.S. cohort.
Methods: In this study, we used the Medical Expenditures Panel Survey to investigate whether functional limitations
explain the difference in medical expenditures between patients with arthritis and joint pain and those without. We
used sequential explanatory linear models to investigate this relationship and accounted for various covariates.
Results: Unadjusted mean expenditures were $10,587 for those with joint pain or arthritis, compared with $3813 for
those without. In a fully adjusted model accounting also for functional limitations, those with joint pain or arthritis paid
$1638 more than those without, a statistically significant difference.
Conclusions: The growing economic and public health burden of arthritis and joint pain, as well as the corresponding
complications of functional, activity, and sensory limitations, calls for an interdisciplinary approach and heightened
awareness among providers to identify strategies that meet the needs of high-risk patients in order to prevent and
delay disease progression.
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Background
Joint pain (including back pain) and arthritis (osteoarth-
ritis, rheumatoid arthritis) are some of the most com-
mon and costly conditions in the United States, affecting
more than 100 million individuals and costing more
than $200 billion per year [1]. Compared with the gen-
eral population, those with diseases characterized by
arthritis/rheumatism and chronic joint pain experience
high rates of functional limitation [1–7]. Functional limi-
tations include those related to limitations in mobility,
self-care, daily activities, and pain [1, 3]. Researchers
have observed significant impacts to the individual
patient as a result of functional limitations, as well as a
quantifiable burden to society. One example is the im-
pact of functional limitation on mental health. Turner
and Turner [8] examined the relationships among phys-
ical disability, mental health, and unemployment. They
found that the three factors were closely related and sug-
gested that this combination could lead to a unique pat-
tern of disadvantage for these individuals. They observed
that those with disabilities were five times more likely to
be involuntarily unemployed and that rates of depression
were higher for all individuals with physical limitations,
but the trend was more pronounced for those without a
job [8]. These unique and compounding factors may
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significantly increase both healthcare use and associated
costs.
Annual direct costs have been estimated on the basis of
reported ambulatory care visits, hospitalizations, diagnos-
tic tests, medications, assistive devices, nonallopathic
treatments, travel to visits, and paid household help [9]. In
other studies focused on specific disorders (i.e., gout, an-
kylosing spondylitis), researchers have explored costs of
illness to the patient and found that functional limitations
contribute to such costs and in some cases are the most
important predictor of total costs in patients [10, 11].
Indirect costs have been estimated from missed work
days or, for retirees and homemakers, the number of
days of activity limitation, as well as employment, house-
hold income, and receipt of supplemental security in-
come for disability [9, 10, 12]. One investigation revealed
that employers lost 28.2 million workdays annually
($4.95 billion in lost income) due to functional limitation
caused by chronic diseases, including arthritis [3]. Add-
itionally, 5.3% of the entire U.S. working population ex-
periences work limitations attributable to arthritis [1].
The monetary cost of these work-specific limitations is
not yet known, but the prevalence at which these limita-
tions occur may have a significant impact on workplace
productivity, especially in physically demanding fields.
Although activity limitations associated with musculo-
skeletal disorders impose a substantial economic burden
on American society, this relationship has not been ex-
plored in a large U.S. cohort. As a result, in this study,
we used the Medical Expenditures Panel Survey (MEPS)
to investigate whether functional limitations explain the
difference in medical expenditures between patients with




Using the MEPS consolidated file for 2011, we analyzed
data from 35,313 adults (ages 18 years and older). Of
this sample, 3793 adults self-reported arthritis or joint
pain of some type. MEPS is an ongoing national house-
hold survey for the civilian noninstitutionalized U.S.
population, with oversampling for blacks and Hispanics
[13]. The data are collected through in-person interviews
and include detailed information on demographic char-
acteristics, self-reported health conditions, health status,
use of medical services, charges and sources of payment,
access to care, satisfaction with care, health insurance
coverage, income, and employment for each person in
the household [13]. The complex survey design provides
weights to account for sampling and stratification, and it
allows generalization to the U.S. population [14, 15]. Use
of the complex survey design enables the 35,313 adults
in the sample population to represent 311,125,758
individuals living in the United States in 2011. In
addition, it allows generalization from the 3793 adults
with self-reported arthritis and/or joint pain in the
MEPS sample to represent the 150,378,648 population
of adults in the United States with arthritis or joint pain.
Dependent variable
The dependent variable was total healthcare expendi-
tures, defined as the sum of direct payments for office-
based medical, hospital inpatient (including zero night
stays) and outpatient, emergency department, pharmacy,
dental, home health, and other medical care. Total
healthcare expenditures represent annual expenditures
for the year of reporting (2011) for each individual. Ex-
penditures represent direct payments, not charges, for
care provided during 2011 and are collected through
both self-report via the household component and
through provider reporting via the medical provider
component of the survey. The medical provider compo-
nent is used to verify information collected at the house-
hold level, as well as to collect information not known
by the household [13].
Independent variable
The primary independent variable was any self-reported
diagnosis with arthritis or joint pain. Joint pain and arth-
ritis are used here as overarching terms; however, they
include any diagnosis of this nature, including various
rheumatic conditions as well as back pain. We were also
interested in the independent variable “any limitation,”
which summarizes whether a person has any limitations
in instrumental activities of daily living, activities of daily
living, function (walking), activity, or sensory (any visual
or hearing impairment). The presence of any limitation
was defined as a positive response to any of these
components.
Covariates
Additional covariates were included on the basis of the
Anderson model for healthcare use, and we categorized
them as predisposing, enabling, and need factors [16].
Predisposing factors included age, race/ethnicity, gender,
region, and metropolitan statistical area (MSA). Age was
categorized into four groups of 18–34 years, 35–44
years, 45–64 years, and 65+ years. Race/ethnicity was
grouped into four categories of non-Hispanic white
(NHW), non-Hispanic black, non-Hispanic other (in-
cluding both Asian and other categories), and Hispanic.
Gender was dichotomized. Region was categorized as
Northeast, Midwest, South, and West. MSA was dichot-
omized as MSA (urban) vs. non-MSA (rural).
Enabling factors included household income, employ-
ment status, education, insurance, and marital status.
Household income was categorized into four groups:
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<$25,000, $25,000–$49,999, $50,000–$74,999, and >
$75,000. Employment was dichotomized. Education was
categorized into four groups as less than high school,
high school, college, and graduate school. Insurance was
categorized into three categories of private, public, and
uninsured. Marital status was categorized into three
groups of never married, separated/divorced/widowed,
and married.
Need factors included health status, body mass index
(BMI), and comorbidities. Comorbidities included
chronic bronchitis, asthma, cancer, coronary heart dis-
ease, myocardial infarction, other heart disease, angina,
diabetes, emphysema, high blood pressure, high choles-
terol, depression, and stroke. Health status was self-
reported into five categories of excellent, very good,
good, fair, and poor. BMI was categorized into four
groups of underweight, normal, overweight, and obese.
Binary indicators of comorbidities were based on a posi-
tive response to a question, “Have you ever been diag-
nosed with ___?,” for each diagnosis.
Statistical analysis
We used sequential explanatory linear models to investi-
gate whether functional limitations explain the differ-
ence in medical expenditures between patients with
arthritis and joint pain and those without. For each
model, we ran a generalized linear model (GLM) using
gamma distribution with total expenditures as the
dependent variable and reporting joint pain or arthritis
as the main independent variable. We then added vari-
ables in blocks according to the Anderson model for
healthcare use categories of predisposing variables, enab-
ling variables, and need variables. Finally, we ran a final
fully adjusted model and added any functional limitation.
After each GLM, we determined the marginal effects
using the margins command in Stata 14.0 statistical soft-
ware (StataCorp, College Station, TX, USA). In order to
generalize our study findings to the U.S. population, the
complex sampling design of the MEPS dataset was taken
into account by using sampling weight, variance estima-
tion stratum, and primary sampling unit in all regression
models and sample demographic estimates.
Results
Table 1 shows the characteristics for U.S. adults with
and without arthritis or joint pain. Of the 3793 adults
who self-reported any arthritis and/or joint pain, 63% re-
ported any limitations, compared with 18% of individ-
uals not reporting arthritis or joint pain. Unadjusted
mean expenditures were $10,587 for those reporting
joint pain or arthritis, compared with $3813 for those
without. Most (87.7%) of U.S. adults reporting arthritis
or joint pain are older than 45 years of age, and they are
predominantly NHW (75.6%) and female (63.1%). The
Table 1 Sample characteristics of U.S. adults with self-reported




U.S. adults in sample
with no reported
arthritis or joint pain
Limitations, %
Any limitations 62.86 18.18
IADL 9.16 1.80
ADL 5.68 1.03
Walk limitations 39.01 6.12
Mean total
expenditure ± SD








Non-Hispanic white 75.64 64.76
Non-Hispanic black 11.66 11.42















< $25,000 48.59 42.88
$25,000–$49,999 29.33 29.80
$50,000-$74,999 12.38 14.70
> $75,000 9.70 12.62
Employment
Not employed 58.05 28.73
Employed 41.95 71.27
Education
Less than high school 17.34 14.66
High school 31.44 27.70
College 40.87 45.59
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majority are not employed (58.1%) and have private in-
surance (63.1%). The most common comorbidities are
high blood pressure (63.3%) and high cholesterol
(55.8%), and the majority are overweight (32.2%) or
obese (42.6%).
As shown in Table 2, adults with self-reported arthritis
or joint pain pay, on average, $6773 more in medical ex-
penditures than those not reporting arthritis or joint
pain. Adjustment decreased the marginal difference to
$4427 when accounting for predisposing factors; $3980
when accounting for predisposing and enabling; and
$2764 when accounting for predisposing, enabling, and
need factors. Finally, in a fully adjusted model account-
ing also for functional limitations, those reporting joint
pain or arthritis paid $1638 more than those without.
Those with functional limitations regardless of comor-
bidity paid $3308 more than those without functional
limitations, which was a higher marginal impact than
any other comorbidity included in the model.
Discussion
Our analyses showed that individuals self-reporting any
diagnosis of arthritis and/or joint pain had substantially
higher mean total healthcare expenditures ($6773) than
individuals without either. In addition, whereas account-
ing for predisposing, enabling, and need variables low-
ered this marginal difference in expenditures, it did not
remove the significance. Adjusting for functional limita-
tions further decreased the difference in healthcare ex-
penditures to $1638, but it did not remove significance.
The marginal decrease resulting from adding functional
limitations into the model was similar in size to the
marginal decrease resulting from adding all other
comorbidities.
This study emphasizes the need for aggressive mea-
sures and strategies for the prevention, early recognition,
and treatment of functional limitations in populations
with arthritis and joint pain because they have significant
impact on differences in medical expenditures. In an in-
vestigation of risk factors for work disability, Allaire et
al. [17] found that two of the most common indicators
of work cessation were severity of disease condition and
physical limitations in arthritis and other rheumatic con-
ditions. Work cessation is especially important to popu-
lations with chronic conditions, often manifested in two
primary concerns. First, loss of employment means loss
of income, and for a population that experiences dispro-
portionately high healthcare costs, losing the primary
source of income could lead many individuals to finan-
cial ruin. Second, according to the Henry J. Kaiser Fam-
ily Foundation, 49% of the U.S. adult population obtain
health insurance through their employers [18]. Thus,
many individuals with arthritis or joint pain who cease
working because of functional limitations will lose their
health insurance and have to pay significant out-of-
pocket expenses or be forced to purchase private insur-
ance, which may be more expensive and/or provide less
coverage.
Our findings are consistent with existing literature that
estimates annual costs associated with some rheumatic
conditions to be $10,000–$50,000 more per patient than
those for the general population [19–22]. Major cost
drivers include inpatient hospitalizations [23], poor
physical and mental health, and low education and em-
ployment levels. Significant functional and emotional
challenges resulting from symptoms, side effects, and
complications may also include anxiety, depression,
mood disorders, and decreased health-related quality of
life [24–27], which further increase service use costs. In
another study, Ozaras et al. [28] observed that in pa-
tients with ankylosing spondylitis and psoriatic arthritis,
disease activity (self-reported pain and symptoms) was
associated with greater physical limitation. Given the dir-
ect relationships observed between disease activity,
Table 1 Sample characteristics of U.S. adults with self-reported
arthritis or joint pain (sample = 3791; population = 311,125,758)
(Continued)
Graduate school 10.35 12.05
Insurance
Any private 63.09 68.99
Public only 30.46 14.67
No insurance 6.45 16.35
Marital status









High blood pressure 63.28 26.05









Abbreviations: ADL Activities of daily living, BMI Body mass index, CVD
Cardiovascular disease, IADL Instrumental activities of daily living, MSA
Metropolitan statistical area
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Table 2 Sequential explanatory model for marginal total healthcare expenditures in those with self-reported joint pain and/or arthritis
Variable Model 1 Model 2 Model 3 Model 4 Model 5
No reported joint pain and/or arthritis
(reference)
– – – – –
Self-reported joint pain and/or
arthritis
$6773* $4427* $3980* $2764* $1638*
Predisposing factors
Age, years
18–24 (reference) – – – –
25–44 $1571* $1873* $2381* $2372*
45–64 $3633* $3717* $3224* $3038*
65+ $6150* $3510* $2087* $1607*
Race
Non-Hispanic white (reference) – – – –
Non-Hispanic black −$883** −$1053** −$1325** −$1287*
Non-Hispanic other −$543 −$448 −$741 −$136
Hispanic −$2196* −$1960* −$1845* −$1683*
Sex
Male (reference) – – – –
Female $1053* $929* $1272* $1383*
Region
Northeast (reference) – – – –
Midwest −$149 $78 −$101 −$168.78
South −$514 −$69 −$458 −$325.85
West $272 $489 $610 $746.14
MSA
Rural (reference) – – – –
Urban $797** $1124* $1216* $1241*
Enabling factors
Income
< $25,000 (reference) – – –
$25,000–$49,999 −$414 −$293 −$44
$50,000–$74,999 $3 $444 $817
> $75,000 $364 $1487*** $1761**
Employment
Not employed (reference) – – –
Employed −$3239 −$2654* −$2018*
Education
Less than high school (reference)
– – –
High school $849*** $1566** $1634*
College $709 $1242* $1305*
Graduate school $1515** $2493* $2457*
Insurance
Any private (reference) – – –
Public only $1526*** $1639 *** $947
No insurance −$3615* −$3875* −$3943*
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comorbidities, and limitations [17, 28–31], the provision
of optimal care to individuals with arthritis and joint
pain is critical. This ultimately results in control of dis-
ease and slows the progression of related complications
such as functional, activity, and sensory limitations.
Though the present study had a number of strengths,
including the generalizability of results to the U.S. popu-
lation, it has some limitations. First, diagnoses were
based on self-report, which may differ from physician
diagnosis. Second, though we attempted to include fac-
tors that could affect the relationship based on a theoret-
ical framework, there are additional factors not in the
dataset, including social determinants such as social sup-
port and emotional distress. Additionally, self-reports
are subject to recall bias, which can introduce random
error into the data. Finally, the data are cross-sectional
in nature, which precludes commentary on causation or
direction of the association.
Conclusions
Our study shows that self-reported arthritis and/or joint
pain of any type is associated with higher total healthcare
expenditures, and though accounting for functional limi-
tations decreases this difference, the difference remains
significant. The growing economic and public health bur-
den of arthritis and joint pain [17, 32, 33], as well as the
corresponding complications of functional, activity, and
sensory limitations, calls for an interdisciplinary approach
and heightened awareness among providers to identify
strategies that meet the needs of high-risk patients in
order to prevent and delay disease progression. This study
provides an estimate for potential savings from future in-
terventions geared toward reduction of any limitations in
patients with arthritis and joint pain. Future researchers
may benefit from this analysis and expand upon it by
examining specifically where these increased costs are
coming from, such as whether the increased cost is due to
Table 2 Sequential explanatory model for marginal total healthcare expenditures in those with self-reported joint pain and/or arthritis
(Continued)
Marital status
Married (reference) – – –
Separated/divorced/widowed $63 $34 −$131





High blood pressure $938* $876*














Abbreviations: ADL Activities of daily living, BMI Body mass index, CVD Cardiovascular disease, IADL Instrumental activities of daily living, MSA Metropolitan
statistical area




****Reference groups compared with those without need factor or risk factor
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a greater number of visits to health professionals, in-
hospital treatments, medications, or other causes. Enu-
merating the breakdown of these expenditures would
allow future development of solutions to target specific
areas with disproportionately high costs.
Abbreviations
ADL: Activities of daily living; BMI: Body mass index; CVD: Cardiovascular
disease; GLM: Generalized linear model; IADL: Instrumental activities of daily
living; MEPS: Medical Expenditures Panel Survey; MSA: Metropolitan statistical
area; NHW: Non-Hispanic white
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